Represents the work of Sudha Biddinger, M.Ph.And a team led by C.Kahn, M.Head of the Joslin Research Section on Obesity and Hormone Action and the Mary K.Professor of Medicine at Harvard Medical School.Is one of the first true insights into the role of the liver in the metabolic syndrome and provides guidance for future therapies," said senior investigator Dr.An internationally recognized researcher in diabetes and metabolism.This connection between atherosclerosis and insulin resistance is one of the most dramatic findings I've seen in 35 years.Syndrome is a collection of medical problems related to insulin resistance, including obesity, glucose intolerance, hypertension, lowered HDL ("good") cholesterol and elevated triglycerides.These are associated with an increased risk of atherosclerosis, the buildup of plaque in the coronary arteries that leads to heart attack and stroke.Study clearly indicates that metabolic syndrome is not merely a collection of abnormalities that should be considered and treated independently, as some experts have advocated," said Kahn and Biddinger.It appears that metabolic syndrome is truly a group of closely linked disturbances in glucose and cholesterol metabolism that stem from a defect in insulin signaling in the liver.Research was funded in part by grants from the National Institutes of Health and The Iacocca Foundation.Center is the world's largest diabetes clinic, diabetes research center and provider of diabetes education.Diabetes Center HOW INTERESTING WAS THIS ARTICLE?Not Very.Read more Please advise regarding the evidence for continuing or stopping aspirin in someone who has had a large gi bleed from severe sigmoid diverticular disease?
Get more Late-breaking clinical results from the inspire study revealed at the ers annual congress in stockholm
